AP NEWS

Innovations in Digital and Targeted Treatment Platforms, 2018 Report - ResearchAndMarkets.com

September 19, 2018

DUBLIN--(BUSINESS WIRE)--Sep 19, 2018--The “Innovations in Digital and Targeted Treatment Platforms” report has been added to ResearchAndMarkets.com’s offering.

This Genetic Technology TOE depicts new life sciences trends across digital targeted therapeutic platforms. Human genetics, antibody therapies, digital oncology platforms, among others, are profiled. The clinical trials scenario for FoundationOne Platform is along depicted.

Key Topics Covered:

1. Advancements in Digital and Targeted Treatment Platforms

Fueling Digital Therapy Platforms Leveraging Human Genetics for Drug Target Discovery Enabling Affordable Antibody Therapies Merging Precision Oncology Platforms for Personalized Healthcare

2. Clinical Trial Analysis and Key Contacts

Analysis of Completed/Ongoing Clinical Trials for Foundation - One Platform Key Contacts

For more information about this report visit https://www.researchandmarkets.com/research/jfz4kz/innovations_in?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180919005708/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/19/2018 02:11 PM/DISC: 09/19/2018 02:11 PM

http://www.businesswire.com/news/home/20180919005708/en

AP RADIO
Update hourly